Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Current challenges and pitfalls in the pharmacological treatment of depression.

Popa-Velea O, Gheorghe IR, Truţescu CI, Purcărea VL.

J Med Life. 2015 Apr-Jun;8(2):181-6.

2.

Third-wave cognitive therapy versus mentalisation-based treatment for major depressive disorder: a randomised clinical trial.

Jakobsen JC, Gluud C, Kongerslev M, Larsen KA, Sørensen P, Winkel P, Lange T, Søgaard U, Simonsen E.

BMJ Open. 2014 Aug 19;4(8):e004903. doi: 10.1136/bmjopen-2014-004903.

3.

Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.

Rustad JK, Stern TA, Hebert KA, Musselman DL.

Prim Care Companion CNS Disord. 2013;15(4). pii: PCC.13r01511. doi: 10.4088/PCC.13r01511. Epub 2013 Aug 15. Review.

4.

Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity.

So M, Yamaguchi S, Hashimoto S, Sado M, Furukawa TA, McCrone P.

BMC Psychiatry. 2013 Apr 15;13:113. doi: 10.1186/1471-244X-13-113.

5.

Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression.

Chen SJ, Chang CH, Tsai HC, Chen ST, Lin CCh.

Neuropsychiatr Dis Treat. 2013;9:397-401. doi: 10.2147/NDT.S40466. Epub 2013 Mar 26.

6.

A model of placebo response in antidepressant clinical trials.

Rutherford BR, Roose SP.

Am J Psychiatry. 2013 Jul;170(7):723-33. doi: 10.1176/appi.ajp.2012.12040474. Review.

7.

Principles underlying the use of multiple informants' reports.

De Los Reyes A, Thomas SA, Goodman KL, Kundey SM.

Annu Rev Clin Psychol. 2013;9:123-49. doi: 10.1146/annurev-clinpsy-050212-185617. Epub 2012 Nov 5. Review.

8.

Major depressive disorders in chronic hemodialysis patients in Nazareth: identification and assessment.

Armaly Z, Farah J, Jabbour A, Bisharat B, Qader AA, Saba S, Zaher M, Haj EE, Hamzi M, Bowirrat A.

Neuropsychiatr Dis Treat. 2012;8:329-38. doi: 10.2147/NDT.S31903. Epub 2012 Jul 25.

9.

Are clinicians' assessments of improvements in children's functioning "global"?

De Los Reyes A, Alfano CA, Beidel DC.

J Clin Child Adolesc Psychol. 2011;40(2):281-94. doi: 10.1080/15374416.2011.546043.

10.

Voice acoustic measures of depression severity and treatment response collected via interactive voice response (IVR) technology.

Mundt JC, Snyder PJ, Cannizzaro MS, Chappie K, Geralts DS.

J Neurolinguistics. 2007 Jan;20(1):50-64.

11.

Correlation between patient and clinician assessments of depression severity in the PREVENT study.

Dunlop BW, Li T, Kornstein SG, Friedman ES, Rothschild AJ, Pedersen R, Ninan P, Keller M.

Psychiatry Res. 2010 May 15;177(1-2):177-83. doi: 10.1016/j.psychres.2010.02.008. Epub 2010 Mar 21.

12.

Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies.

Loftis JM, Huckans M, Morasco BJ.

Neurobiol Dis. 2010 Mar;37(3):519-33. doi: 10.1016/j.nbd.2009.11.015. Epub 2009 Nov 26. Review.

13.
14.
16.

The PHQ-9: validity of a brief depression severity measure.

Kroenke K, Spitzer RL, Williams JB.

J Gen Intern Med. 2001 Sep;16(9):606-13.

Supplemental Content

Support Center